Study Shows Fewer People Tried to Quit Smoking During COVID-19 Pandemic

A new study led by researchers at the American Cancer Society shows serious smoking cessation activity declined among adults in the United States immediately after the onset of COVID-19 and persisted for over a year. Declines in attempts to quit smoking were largest among persons experiencing disproportionately negative outcomes during COVID-19, including Black people, people with comorbidities, middle-aged people, and lower educated people. The data was published today in the Journal of the American Medical Association (JAMA) Network Open.

UC San Diego Researcher Studying Menthol Cigarettes Talks about FDA Ban

On April 29, 2021, the U.S. Food and Drug Administration (FDA) proclaimed its ban on menthol cigarettes and all flavored cigars as a commitment to reduce addiction and youth experimentation, improve quitting among current smokers and address health disparities. Thanks…

Quit the Hookah! Lung Damage, Inflammation Is Reversible with Smoking Cessation

New research finds that quitting smoking is an effective way to resolve impaired lung function and airway inflammation associated with waterpipe smoking. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.

Protect Your Bladder: Quit Smoking

Your bladder probably isn’t your favorite topic of conversation, but knowing when to talk to your doctor about it is crucial to your health. If you experience frequent and/or painful urination, or you notice blood in your urine, telling your primary care provider is the first step to diagnosing a problem and finding the right care. More often than not, these symptoms are caused by non-life-threatening conditions like urinary tract infection, overactive bladder or, in men, an enlarged prostate. But they also could be symptoms of bladder cancer, the sixth most common form of cancer in the United States.

$11.4 million NIH grant advances drug to treat nicotine addiction

Scientists at Sanford Burnham Prebys Medical Discovery Institute, Camino Pharma, LLC and University of California San Diego School of Medicine have been awarded an $11.4 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to advance a novel drug candidate for nicotine addiction into first-in-human Phase 1 studies. The drug targets a neuronal signaling pathway underlying addictive behaviors, and would be a first-in-class medication to help people quit smoking.

New National Survey Shows that 73% of people making New Year’s resolutions agree that recommitting every Monday can help them stay on track

DDG (Data Decisions Group) and the Monday Campaigns, a public health initiative, conducted research that showed that 20% of people that make New Year’s resolutions fall off in January and by July, 43% have given up on some of their top resolutions. People surveyed responded favorably to the idea of a “Monday Resolution”— with 73% of those who made a resolution in 2019 saying that recommitting every Monday would help them stay on track.